| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schistosoma mansoni | 50 | 2026 | 50 | 8.720 |
Why?
|
| NADH, NADPH Oxidoreductases | 21 | 2026 | 21 | 3.250 |
Why?
|
| Multienzyme Complexes | 20 | 2026 | 32 | 3.190 |
Why?
|
| Schistosomicides | 12 | 2026 | 12 | 2.890 |
Why?
|
| Enzyme Inhibitors | 14 | 2026 | 114 | 2.610 |
Why?
|
| Helminth Proteins | 12 | 2015 | 14 | 2.080 |
Why?
|
| Thioredoxin-Disulfide Reductase | 12 | 2026 | 12 | 2.040 |
Why?
|
| Animals | 67 | 2026 | 3302 | 2.000 |
Why?
|
| Schistosomiasis | 8 | 2023 | 8 | 1.900 |
Why?
|
| Schistosomiasis mansoni | 14 | 2022 | 14 | 1.840 |
Why?
|
| Oxidation-Reduction | 18 | 2026 | 64 | 1.410 |
Why?
|
| Gene Expression Profiling | 8 | 2013 | 109 | 1.280 |
Why?
|
| Cryptosporidium parvum | 2 | 2026 | 2 | 1.150 |
Why?
|
| Aminoacyltransferases | 3 | 2013 | 3 | 1.130 |
Why?
|
| Anthelmintics | 6 | 2020 | 8 | 0.970 |
Why?
|
| Mice | 22 | 2026 | 1249 | 0.920 |
Why?
|
| Protozoan Proteins | 1 | 2025 | 1 | 0.910 |
Why?
|
| Cryptosporidium | 1 | 2025 | 2 | 0.900 |
Why?
|
| Drug Design | 5 | 2013 | 21 | 0.870 |
Why?
|
| Antimalarials | 5 | 2026 | 11 | 0.860 |
Why?
|
| Molecular Sequence Data | 21 | 2013 | 185 | 0.850 |
Why?
|
| Auranofin | 8 | 2025 | 8 | 0.760 |
Why?
|
| Amino Acid Sequence | 18 | 2013 | 151 | 0.730 |
Why?
|
| Peroxiredoxins | 10 | 2021 | 11 | 0.720 |
Why?
|
| Antineoplastic Agents | 4 | 2025 | 197 | 0.710 |
Why?
|
| NADP | 6 | 2024 | 10 | 0.710 |
Why?
|
| Naphthoquinones | 5 | 2024 | 7 | 0.690 |
Why?
|
| Peroxidases | 4 | 2006 | 6 | 0.660 |
Why?
|
| Ancylostoma | 3 | 2019 | 3 | 0.650 |
Why?
|
| Recombinant Proteins | 12 | 2013 | 163 | 0.650 |
Why?
|
| Oxidative Stress | 6 | 2025 | 85 | 0.650 |
Why?
|
| Models, Molecular | 9 | 2026 | 80 | 0.610 |
Why?
|
| Glutathione | 8 | 2025 | 23 | 0.600 |
Why?
|
| DNA, Helminth | 6 | 2013 | 6 | 0.580 |
Why?
|
| Thioredoxins | 6 | 2025 | 8 | 0.580 |
Why?
|
| Antigens, Helminth | 4 | 2007 | 4 | 0.510 |
Why?
|
| Gold | 3 | 2026 | 3 | 0.500 |
Why?
|
| Phytochelatins | 2 | 2013 | 2 | 0.500 |
Why?
|
| Glutathione Reductase | 5 | 2023 | 6 | 0.490 |
Why?
|
| Albumins | 2 | 2006 | 18 | 0.490 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2015 | 2 | 0.480 |
Why?
|
| Oxadiazoles | 3 | 2014 | 7 | 0.460 |
Why?
|
| Thioredoxin Reductase 1 | 2 | 2025 | 2 | 0.460 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2025 | 17 | 0.450 |
Why?
|
| Hypertension, Pulmonary | 2 | 2026 | 20 | 0.440 |
Why?
|
| Plasmodium falciparum | 4 | 2026 | 5 | 0.440 |
Why?
|
| Humans | 33 | 2026 | 23210 | 0.430 |
Why?
|
| Schistosoma | 3 | 2023 | 3 | 0.430 |
Why?
|
| Crystallography, X-Ray | 7 | 2026 | 12 | 0.430 |
Why?
|
| Parasitology | 2 | 2011 | 2 | 0.430 |
Why?
|
| High-Throughput Screening Assays | 3 | 2020 | 6 | 0.420 |
Why?
|
| Gene Expression | 3 | 2013 | 180 | 0.420 |
Why?
|
| Cloning, Molecular | 10 | 2011 | 29 | 0.410 |
Why?
|
| Coordination Complexes | 2 | 2026 | 3 | 0.410 |
Why?
|
| Geranyltranstransferase | 1 | 2013 | 1 | 0.410 |
Why?
|
| Diphosphonates | 1 | 2013 | 16 | 0.400 |
Why?
|
| Structure-Activity Relationship | 8 | 2026 | 36 | 0.390 |
Why?
|
| Sequence Homology, Amino Acid | 7 | 2013 | 35 | 0.390 |
Why?
|
| Ovum | 2 | 2015 | 2 | 0.380 |
Why?
|
| Drug Evaluation, Preclinical | 5 | 2019 | 26 | 0.380 |
Why?
|
| Cestode Infections | 1 | 2012 | 1 | 0.380 |
Why?
|
| Platyhelminths | 1 | 2012 | 1 | 0.380 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2005 | 94 | 0.370 |
Why?
|
| Female | 19 | 2026 | 13149 | 0.370 |
Why?
|
| Biocatalysis | 1 | 2011 | 1 | 0.350 |
Why?
|
| Neoplasm Proteins | 2 | 2002 | 52 | 0.350 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 49 | 0.340 |
Why?
|
| Disulfides | 3 | 2023 | 10 | 0.340 |
Why?
|
| Life Cycle Stages | 3 | 2011 | 4 | 0.330 |
Why?
|
| Male | 15 | 2026 | 12665 | 0.320 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2009 | 4 | 0.310 |
Why?
|
| Sequence Alignment | 6 | 2009 | 21 | 0.280 |
Why?
|
| B-Lymphocytes | 4 | 2005 | 49 | 0.280 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2020 | 5 | 0.280 |
Why?
|
| Praziquantel | 3 | 2023 | 4 | 0.280 |
Why?
|
| Proteome | 1 | 2007 | 23 | 0.260 |
Why?
|
| Kinetics | 5 | 2013 | 176 | 0.250 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2006 | 2 | 0.250 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2026 | 1 | 0.250 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2026 | 2 | 0.250 |
Why?
|
| Xanthones | 1 | 2026 | 1 | 0.240 |
Why?
|
| Organogold Compounds | 1 | 2026 | 1 | 0.240 |
Why?
|
| Mefloquine | 1 | 2026 | 3 | 0.240 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2025 | 1 | 0.240 |
Why?
|
| Antiparasitic Agents | 2 | 2024 | 2 | 0.230 |
Why?
|
| Cryptosporidiosis | 1 | 2025 | 2 | 0.230 |
Why?
|
| Prodrugs | 1 | 2024 | 1 | 0.220 |
Why?
|
| Lymphocyte Activation | 2 | 2005 | 76 | 0.220 |
Why?
|
| Biomphalaria | 3 | 2009 | 3 | 0.220 |
Why?
|
| Malaria, Falciparum | 2 | 2013 | 2 | 0.220 |
Why?
|
| Inflammation | 1 | 2026 | 230 | 0.220 |
Why?
|
| Gene Expression Regulation | 3 | 2011 | 227 | 0.210 |
Why?
|
| Drug Discovery | 3 | 2020 | 12 | 0.210 |
Why?
|
| Brugia malayi | 2 | 2022 | 2 | 0.210 |
Why?
|
| Onchocerca volvulus | 2 | 2022 | 2 | 0.210 |
Why?
|
| Proteins | 2 | 2021 | 52 | 0.210 |
Why?
|
| Open Reading Frames | 2 | 2015 | 9 | 0.210 |
Why?
|
| Drug Resistance | 2 | 2015 | 45 | 0.200 |
Why?
|
| Nitric Oxide Donors | 3 | 2014 | 7 | 0.200 |
Why?
|
| Escherichia coli | 3 | 2013 | 43 | 0.200 |
Why?
|
| Phylogeny | 5 | 2012 | 43 | 0.200 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2003 | 8 | 0.200 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2023 | 1 | 0.200 |
Why?
|
| Reactive Oxygen Species | 4 | 2015 | 104 | 0.190 |
Why?
|
| Sequence Analysis, DNA | 5 | 2013 | 48 | 0.190 |
Why?
|
| Adenylosuccinate Lyase | 1 | 2002 | 1 | 0.190 |
Why?
|
| Cysteine | 4 | 2022 | 8 | 0.190 |
Why?
|
| Oxidoreductases | 1 | 2002 | 9 | 0.180 |
Why?
|
| Parasites | 1 | 2022 | 1 | 0.180 |
Why?
|
| Plants, Medicinal | 1 | 2022 | 3 | 0.180 |
Why?
|
| Host-Parasite Interactions | 3 | 2012 | 3 | 0.180 |
Why?
|
| Glutathione Peroxidase | 3 | 2006 | 6 | 0.180 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 125 | 0.180 |
Why?
|
| Biological Products | 1 | 2022 | 31 | 0.170 |
Why?
|
| Cell Line, Tumor | 4 | 2025 | 246 | 0.170 |
Why?
|
| Hydrogen Peroxide | 4 | 2008 | 40 | 0.170 |
Why?
|
| Egg Proteins | 1 | 2001 | 1 | 0.170 |
Why?
|
| Nanostructures | 1 | 2021 | 9 | 0.170 |
Why?
|
| Base Sequence | 7 | 2006 | 103 | 0.170 |
Why?
|
| Helminthiasis | 1 | 2020 | 1 | 0.170 |
Why?
|
| Protozoan Infections | 1 | 2020 | 1 | 0.170 |
Why?
|
| Antiprotozoal Agents | 1 | 2020 | 8 | 0.170 |
Why?
|
| Expressed Sequence Tags | 3 | 2007 | 5 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 60 | 0.160 |
Why?
|
| Selenocysteine | 3 | 2011 | 3 | 0.160 |
Why?
|
| Molecular Structure | 4 | 2024 | 14 | 0.150 |
Why?
|
| Oviposition | 1 | 2019 | 2 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 3 | 2007 | 362 | 0.150 |
Why?
|
| Solubility | 3 | 2013 | 19 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 131 | 0.140 |
Why?
|
| Neoplasms | 1 | 2020 | 219 | 0.140 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2011 | 17 | 0.140 |
Why?
|
| Protein Conformation | 3 | 2013 | 65 | 0.130 |
Why?
|
| Computational Biology | 3 | 2012 | 14 | 0.130 |
Why?
|
| Nitric Oxide | 3 | 2014 | 72 | 0.130 |
Why?
|
| RNA, Messenger | 2 | 2011 | 283 | 0.120 |
Why?
|
| Substrate Specificity | 2 | 2013 | 21 | 0.120 |
Why?
|
| Catalysis | 3 | 2013 | 17 | 0.120 |
Why?
|
| Introns | 3 | 2009 | 14 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2025 | 23 | 0.110 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2015 | 1 | 0.110 |
Why?
|
| Erythrocytes | 1 | 2015 | 17 | 0.110 |
Why?
|
| Onchocerciasis | 1 | 2015 | 1 | 0.110 |
Why?
|
| Microfilariae | 1 | 2015 | 2 | 0.110 |
Why?
|
| Elephantiasis, Filarial | 1 | 2015 | 2 | 0.110 |
Why?
|
| Loiasis | 1 | 2015 | 2 | 0.110 |
Why?
|
| Apoptosis | 2 | 2026 | 196 | 0.110 |
Why?
|
| Endothelial Cells | 2 | 2026 | 59 | 0.110 |
Why?
|
| Cell Proliferation | 2 | 2025 | 166 | 0.110 |
Why?
|
| Isoquinolines | 1 | 2014 | 12 | 0.110 |
Why?
|
| Pyrazines | 1 | 2014 | 12 | 0.110 |
Why?
|
| DNA, Complementary | 2 | 2007 | 24 | 0.110 |
Why?
|
| Gene Library | 2 | 2007 | 7 | 0.110 |
Why?
|
| Lung | 2 | 2026 | 141 | 0.100 |
Why?
|
| S-Nitrosothiols | 1 | 2014 | 1 | 0.100 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2014 | 1 | 0.100 |
Why?
|
| Ancylostomiasis | 1 | 2013 | 1 | 0.100 |
Why?
|
| Quinoxalines | 1 | 2013 | 6 | 0.100 |
Why?
|
| Proteomics | 1 | 2014 | 61 | 0.100 |
Why?
|
| Genome, Helminth | 2 | 2012 | 2 | 0.100 |
Why?
|
| Retroelements | 2 | 2003 | 2 | 0.100 |
Why?
|
| Peptidyl Transferases | 1 | 2013 | 1 | 0.100 |
Why?
|
| Xenobiotics | 1 | 2013 | 1 | 0.100 |
Why?
|
| Hydrolases | 1 | 2013 | 2 | 0.100 |
Why?
|
| Zygote | 1 | 2012 | 2 | 0.100 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 96 | 0.100 |
Why?
|
| Genes, Helminth | 3 | 2009 | 3 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 8 | 0.090 |
Why?
|
| Quinolines | 1 | 2012 | 8 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 315 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2012 | 4 | 0.090 |
Why?
|
| Metals | 1 | 2013 | 96 | 0.090 |
Why?
|
| Molecular Weight | 2 | 2002 | 20 | 0.090 |
Why?
|
| Mice, Inbred C3H | 2 | 2002 | 16 | 0.090 |
Why?
|
| Models, Chemical | 1 | 2012 | 42 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2003 | 132 | 0.090 |
Why?
|
| Precipitin Tests | 2 | 2002 | 9 | 0.090 |
Why?
|
| Cluster Analysis | 2 | 2012 | 39 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 17 | 0.090 |
Why?
|
| Cadmium | 1 | 2011 | 11 | 0.090 |
Why?
|
| Alternative Splicing | 1 | 2011 | 16 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2003 | 338 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2011 | 15 | 0.090 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 80 | 0.080 |
Why?
|
| Cell Line | 3 | 2015 | 244 | 0.080 |
Why?
|
| Methionine | 1 | 2009 | 1 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 31 | 0.080 |
Why?
|
| Interleukin-4 | 2 | 2008 | 17 | 0.070 |
Why?
|
| DNA | 4 | 2009 | 98 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2026 | 278 | 0.070 |
Why?
|
| Fasciola hepatica | 1 | 2008 | 1 | 0.070 |
Why?
|
| Fascioliasis | 1 | 2008 | 1 | 0.070 |
Why?
|
| Macrophage Activation | 1 | 2008 | 7 | 0.070 |
Why?
|
| Th2 Cells | 1 | 2008 | 15 | 0.070 |
Why?
|
| Antirheumatic Agents | 1 | 2009 | 84 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2008 | 388 | 0.070 |
Why?
|
| Interleukin-2 | 2 | 2005 | 22 | 0.070 |
Why?
|
| Amides | 1 | 2008 | 15 | 0.070 |
Why?
|
| Cattle | 2 | 2020 | 110 | 0.070 |
Why?
|
| Macrophages | 1 | 2008 | 78 | 0.070 |
Why?
|
| Physical Chromosome Mapping | 2 | 2009 | 2 | 0.070 |
Why?
|
| Exons | 2 | 2009 | 29 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 11 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 24 | 0.070 |
Why?
|
| Disease Vectors | 1 | 2007 | 1 | 0.070 |
Why?
|
| RNA, Helminth | 1 | 2007 | 1 | 0.070 |
Why?
|
| Sex Differentiation | 1 | 2007 | 2 | 0.070 |
Why?
|
| Genes, Homeobox | 1 | 2007 | 4 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2026 | 528 | 0.070 |
Why?
|
| RNA Interference | 1 | 2007 | 36 | 0.060 |
Why?
|
| Markov Chains | 1 | 2006 | 30 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2007 | 140 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 6 | 0.060 |
Why?
|
| Palladium | 1 | 2026 | 1 | 0.060 |
Why?
|
| Parasite Egg Count | 2 | 2003 | 2 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2008 | 91 | 0.060 |
Why?
|
| Sex Factors | 1 | 2007 | 399 | 0.060 |
Why?
|
| Antioxidants | 1 | 2006 | 56 | 0.060 |
Why?
|
| Terminal Repeat Sequences | 2 | 2002 | 3 | 0.060 |
Why?
|
| Mice, Inbred CBA | 1 | 2005 | 1 | 0.060 |
Why?
|
| Interleukin-5 | 1 | 2005 | 3 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2002 | 37 | 0.060 |
Why?
|
| Epitopes | 1 | 2005 | 38 | 0.060 |
Why?
|
| Immunity, Cellular | 1 | 2005 | 33 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 112 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2005 | 72 | 0.060 |
Why?
|
| Cycloaddition Reaction | 1 | 2024 | 2 | 0.060 |
Why?
|
| Stereoisomerism | 1 | 2024 | 4 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2024 | 27 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 24 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 19 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2004 | 12 | 0.050 |
Why?
|
| Electrons | 1 | 2004 | 15 | 0.050 |
Why?
|
| Protein Binding | 1 | 2004 | 112 | 0.050 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2023 | 1 | 0.050 |
Why?
|
| Caveolin 1 | 1 | 2023 | 11 | 0.050 |
Why?
|
| Immune Sera | 1 | 2003 | 4 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2003 | 4 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 4 | 0.050 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 9 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2003 | 12 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2023 | 35 | 0.050 |
Why?
|
| Genome | 1 | 2003 | 7 | 0.050 |
Why?
|
| Transfection | 1 | 2003 | 115 | 0.050 |
Why?
|
| Antibodies, Helminth | 1 | 2003 | 1 | 0.050 |
Why?
|
| Schistosoma haematobium | 1 | 2003 | 1 | 0.050 |
Why?
|
| Schistosomiasis haematobia | 1 | 2003 | 1 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2003 | 13 | 0.050 |
Why?
|
| Peroxiredoxin III | 1 | 2002 | 1 | 0.050 |
Why?
|
| Sequence Analysis, Protein | 1 | 2002 | 3 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 67 | 0.050 |
Why?
|
| Glutaredoxins | 1 | 2002 | 1 | 0.050 |
Why?
|
| Selenoproteins | 1 | 2022 | 3 | 0.050 |
Why?
|
| Herbal Medicine | 1 | 2022 | 3 | 0.050 |
Why?
|
| Models, Biological | 1 | 2004 | 302 | 0.050 |
Why?
|
| Kenya | 1 | 2022 | 4 | 0.050 |
Why?
|
| Purines | 1 | 2002 | 41 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 20 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2002 | 91 | 0.040 |
Why?
|
| Biopolymers | 1 | 2021 | 5 | 0.040 |
Why?
|
| Drug Evaluation | 1 | 2020 | 19 | 0.040 |
Why?
|
| Time Factors | 1 | 2004 | 1264 | 0.040 |
Why?
|
| Chromosomes, Bacterial | 1 | 2000 | 2 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2019 | 34 | 0.040 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2015 | 1 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 1 | 0.030 |
Why?
|
| Electrochemistry | 1 | 2015 | 37 | 0.030 |
Why?
|
| Chitinases | 1 | 1995 | 1 | 0.030 |
Why?
|
| Hexosaminidases | 1 | 1995 | 1 | 0.030 |
Why?
|
| Streptomyces | 1 | 1995 | 1 | 0.030 |
Why?
|
| Acetylglucosaminidase | 1 | 1995 | 2 | 0.030 |
Why?
|
| Benzyl Compounds | 1 | 2015 | 1 | 0.030 |
Why?
|
| Vitamin K 3 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Malaria | 1 | 2015 | 3 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 153 | 0.030 |
Why?
|
| Diethylcarbamazine | 1 | 2015 | 1 | 0.030 |
Why?
|
| Filaricides | 1 | 2015 | 1 | 0.030 |
Why?
|
| Gerbillinae | 1 | 2015 | 1 | 0.030 |
Why?
|
| Ivermectin | 1 | 2015 | 1 | 0.030 |
Why?
|
| Loa | 1 | 2015 | 1 | 0.030 |
Why?
|
| Albendazole | 1 | 2015 | 2 | 0.030 |
Why?
|
| Haplorhini | 1 | 2015 | 8 | 0.030 |
Why?
|
| Drug Repositioning | 1 | 2015 | 4 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 1994 | 5 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1994 | 51 | 0.030 |
Why?
|
| Genetic Variation | 1 | 1994 | 72 | 0.030 |
Why?
|
| Nitrosation | 1 | 2014 | 2 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 33 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2013 | 13 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2013 | 13 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 599 | 0.020 |
Why?
|
| Hemin | 1 | 2012 | 1 | 0.020 |
Why?
|
| Methemoglobin | 1 | 2012 | 1 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 38 | 0.020 |
Why?
|
| Peroxidase | 1 | 2012 | 15 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 8 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 21 | 0.020 |
Why?
|
| Neurons | 1 | 2014 | 273 | 0.020 |
Why?
|
| Animal Structures | 1 | 2011 | 1 | 0.020 |
Why?
|
| Biological Availability | 1 | 2009 | 15 | 0.020 |
Why?
|
| Selenium | 1 | 2009 | 7 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2009 | 10 | 0.020 |
Why?
|
| Immunization | 1 | 2008 | 12 | 0.020 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2008 | 1 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2008 | 9 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2008 | 10 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2008 | 10 | 0.020 |
Why?
|
| Rats | 1 | 2009 | 624 | 0.020 |
Why?
|
| Nitrosamines | 1 | 2008 | 1 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2008 | 463 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 1994 | 114 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 6962 | 0.010 |
Why?
|
| Genomic Library | 1 | 2003 | 1 | 0.010 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2003 | 3 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 36 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2003 | 18 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 47 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2003 | 82 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2000 | 3 | 0.010 |
Why?
|
| DNA Probes | 1 | 2000 | 7 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2000 | 6 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2000 | 24 | 0.010 |
Why?
|
| Adolescent | 1 | 2003 | 1884 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1995 | 126 | 0.010 |
Why?
|
| DNA Primers | 1 | 1994 | 50 | 0.010 |
Why?
|
| RNA | 1 | 1994 | 29 | 0.010 |
Why?
|
| DNA, Protozoan | 1 | 1994 | 3 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1994 | 4 | 0.010 |
Why?
|
| Middle Aged | 1 | 2003 | 7983 | 0.010 |
Why?
|